Disease-specific risk for an osteonecrosis of the jaw under bisphosphonate therapy


Osteonecrosis of the jaw (ONJ) presents a severe side-effect of intravenous bisphosphonate (i.v. BP) treatment; yet, the pathoethiological influence of the underlying disease which indicated that treatment remains unclear. We studied a large register of subjects who suffered an ONJ (n = 356) under i.v. BP therapy and characterized them according to… (More)
DOI: 10.1007/s00432-009-0662-9

4 Figures and Tables


  • Presentations referencing similar topics